GlobalData on MSN1d
Boehringer Ingelheim and Salipro enter drug discovery partnership
The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
Contract Pharma2d
Boehringer Ingelheim Taps Salipro Biotech to Accelerate Pipeline Programs
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Saniona AB: Saniona and Boehringer Ingelheim extend research collaboration with one year
Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the ongoing ion channel research collaboration with Boehringer Ingelheim has been extended with one year. "The p ...
pharmaphorum5d
Changing Faces: Pharma and biotech hires – February 2025
February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...
PharmaTimes12d
Professor Dr Uli Brödl
Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the ...
New Jersey Business Magazine8d
O’Connor Named CEO at qordata
Princeton-based qordata has appointed Michael T. O’Connor as its new CEO. With a distinguished career at the intersection of ...
Le Lézard2d
Syra Health Secures $660,000 Population Health Contract Extension
Syra Health Corp. , a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health ...